These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18509119)

  • 1. Exploiting a research underclass in phase 1 clinical trials.
    Elliott C; Abadie R
    N Engl J Med; 2008 May; 358(22):2316-7. PubMed ID: 18509119
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase 1 oncology trials and informed consent.
    Miller FG; Joffe S
    J Med Ethics; 2013 Dec; 39(12):761-4. PubMed ID: 23161617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human subjects in weapons research.
    Caplan AL; Sankar P
    Science; 2002 Nov; 298(5595):923. PubMed ID: 12411671
    [No Abstract]   [Full Text] [Related]  

  • 4. Inside information: Financial conflicts of interest for research subjects in early phase clinical trials.
    Helft PR; Ratain MJ; Epstein RA; Siegler M
    J Natl Cancer Inst; 2004 May; 96(9):656-61. PubMed ID: 15126602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two-faced angel: do phase I clinical trials have a place in modern hospice?
    Ross DS
    Penn Bioeth J; 2006; 2(2):46-9. PubMed ID: 17146915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out of sight, out of mind: how Harvard University exploited rural Chinese villagers for their DNA.
    Keim B
    Genewatch; 2003; 16(5):10-1. PubMed ID: 15025121
    [No Abstract]   [Full Text] [Related]  

  • 7. Should trial subjects be unionised?
    Mamdani B
    Indian J Med Ethics; 2008; 5(3):138-40. PubMed ID: 18754241
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic misconception in early phase gene transfer trials.
    Henderson GE; Easter MM; Zimmer C; King NM; Davis AM; Rothschild BB; Churchill LR; Wilfond BS; Nelson DK
    Soc Sci Med; 2006 Jan; 62(1):239-53. PubMed ID: 16000230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric ethics and early-phase childhood cancer research: conflicted goals and the prospect of benefit.
    Kodish E
    Account Res; 2003; 10(1):17-25. PubMed ID: 14552299
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic research in the Third World (developing) countries--science or exploitation?
    Mullings A
    St Thomas Law Rev; 2001; 13(4):955-64. PubMed ID: 12661584
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of Zairian children in HIV vaccine experimentation: a cross-cultural study in medical ethics.
    Nairn TA
    Annu Soc Christ Ethics; 1993; ():223-43. PubMed ID: 12568073
    [No Abstract]   [Full Text] [Related]  

  • 12. Whatever Happened to Human Experimentation?
    Elliott C
    Hastings Cent Rep; 2016; 46(1):8-11. PubMed ID: 26659598
    [No Abstract]   [Full Text] [Related]  

  • 13. Equipoise and the ethics of clinical research revisited.
    Miller FG
    Am J Bioeth; 2006; 6(4):59-61; discussion W42-5. PubMed ID: 16885110
    [No Abstract]   [Full Text] [Related]  

  • 14. Historical vulnerability and special scrutiny: precautions against discrimination in medical research.
    Silvers A
    Am J Bioeth; 2004; 4(3):56-7; discussion W32. PubMed ID: 16192142
    [No Abstract]   [Full Text] [Related]  

  • 15. The ubiquity and utility of the therapeutic misconception.
    Dresser R
    Soc Philos Policy; 2002; 19(2):271-94. PubMed ID: 12678090
    [No Abstract]   [Full Text] [Related]  

  • 16. MRI research proposals involving child subjects: concerns hindering research ethics boards from approving them and a checklist to help evaluate them.
    Shiloff JD; Magwood B; Malisza KL
    Camb Q Healthc Ethics; 2011 Jan; 20(1):115-29. PubMed ID: 21223616
    [No Abstract]   [Full Text] [Related]  

  • 17. "Paid to Endure": Paid Research Participation, Passivity, and the Goods of Work.
    Malmqvist E
    Am J Bioeth; 2019 Sep; 19(9):11-20. PubMed ID: 31419192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A public culture for guinea pigs: US human research subjects after the Tuskegee study.
    Weinstein M
    Sci Cult (Lond); 2001 Jun; 10(2):195-223. PubMed ID: 15971362
    [No Abstract]   [Full Text] [Related]  

  • 19. Adolescents as doubly-vulnerable research subjects.
    Kopelman LM
    Am J Bioeth; 2004; 4(1):50-2. PubMed ID: 15035950
    [No Abstract]   [Full Text] [Related]  

  • 20. Why wasn't an investigational new drug (IND) application required before appropriate study?
    Maloney DM
    Hum Res Rep; 2004 Mar; 19(3):6-7. PubMed ID: 15139342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.